ArticleCancers2020
Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity.
Tina Bagratuni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it
ArticleCancers2020
Tina Bagratuni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.